Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million ...Middle East

HERZLIYA, Israel and CALGARY, AB, May 27, 2024 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce its...

Hence then, the article about innocan pharma reports first quarter 2024 results with revenue growth of over 4x to 6 8 million was published today ( Monday 27/05/2024 - 11:09 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million )

Also on site :

• Russia-Ukraine war: List of key events, day 1,428
• Thrash Metal Icon Reveals Truth About Final Album of 43-Year-Old Band
• Christina Haack Stuns in Bikini With Boyfriend on Tropical Getaway